Ibuprofen Linked to Breast Cancer

A new study published on June 1 in the Journal of the National Cancer Institute, suggests that Ibuprofen, one of the most widely used painkillers, raises the risk of breast cancer. The study found that women taking the drug on a daily long-term basis had a significantly increased risk of contracting breast cancer.

The research followed more than 114,000 Californian women aged 22-85, all of them free from breast cancer at the start of the trials. All were asked to give details of the pills and medicines they consumed. During the six-year study period 2,391 of the women contracted breast cancer. They estimate that in perhaps a few dozen of the cancer cases Ibuprofen use may have played a part.

I am not surprised by the results of this study. We know that NSAIDS cause liver problems and the liver is the key organ for hormone metabolism in the body. NSAIDS also inhibit the CP450 enzyme system. This system ensures that toxins that contribute to increased breast cancer are detoxified and when it is disrupted our risk of breast cancer increases. The development of breast cancer is closely linked to hormone levels and their fluctuations, which can be affected by a range of drugs, environmental hormones and toxins.

With all the concerns surrounding the COX-2 inhibitor medications and now Ibuprofen many people are looking for safe alternatives. Read Get a Grip on Arthritis and Other Inflammatory Disorders on alternatives to NSAIDS and Acetaminophen.


Leave a Reply